Frontlight ResearchEarly access
Trial site
Indiana University Health Melvin and Bren Simon Cancer Center
- 5running trials
- 6closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Follicular lymphoma1 trial
- Liver and biliary tract cancer1 trial
- Lung cancer1 trial
- Mantle cell lymphoma1 trial
- Multiple myeloma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 27 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Completed6 trials
- Active, not recruiting4 trials
- Recruiting1 trial
- Lead sponsor
- Pfizer2 trials
- Syndax Pharmaceuticals2 trials
- Adrienne G. Waks1 trial
- Georgetown University1 trial
- ImmunoVaccine Technologies, Inc. (IMV Inc.)1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Active, not recruiting
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma1 recruiting
Closed trials
Completed
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
Completed
PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026